Orexigen Therapeutics (OREX)
Orexigen Therapeutics Key Statistics
Pro Data ExportCurrent Valuation
Dividends and Shares
| Dividend | |
| Dividend Yield | 0.00% |
| Cash Div. Payout Ratio TTM Pro | Go Pro |
| Payout Ratio TTM Pro | Go Pro |
| Dividend Date | |
| Ex-Dividend Date | |
| Last Split Factor | |
| Last Split Date |
Profitability
| Gross Profit Margin | |
| EBITDA Margin TTM Pro | Go Pro |
| Operating Margin TTM Pro | Go Pro |
| Profit Margin | -1215% |
Management Effectiveness
Liquidity and Solvency
| Altman Z-Score Pro | Go Pro |
| Current Ratio | 16.59 |
| Debt to Equity Ratio | 0.00 |
| KZ Index Pro | Go Pro |
| Tangible Common Equity Ratio Pro | Go Pro |
| Times Interest Earned TTM Pro | Go Pro |
Stock Price Performance
| Beta Pro | Go Pro |
| 1 Month Stock Returns | -4.29% |
| Year to Date Stock Returns | 108.1% |
| 1 Year Stock Returns | 18.37% |
| 3 Year Stock Returns | -5.90% |
| 52 Week High | 5.14 |
| 52 Week Low | 1.22 |
Income Statement
| Revenues TTM | 3.428M |
| Revenue Per Share TTM | 0.0506 |
| Revenue Growth | -53.12% |
| Gross Profit TTM | 3.428M |
| EBITDA TTM Pro | Go Pro |
| Income from Cont. Ops Pro | Go Pro |
| Net Income TTM | -26.87M |
| Earnings Per Share TTM | -0.50 |
| Other Comprehensive Income Pro | Go Pro |
Cash Flow Statement
| Cash Investing TTM | -28.70M |
| Cash Financing TTM | 85.93M |
| Cash Operations TTM | -23.42M |
| Capital Expenditures | 0.00 |
Share Statistics
| Shares Outstanding | 67.74M |
Balance Sheet
| Cash and ST Investments | 138.58M |
| Total Assets | 140.73M |
| Liabilities | 49.79M |
| Book Value | 90.94M |
| Book Value per Share | 1.342 |
| Tangible Book Value Pro | Go Pro |
| Tangible Book Value Per Share Pro | Go Pro |
| Long Term Debt | 0.00 |
Earnings Quality
| Accruals Pro | Go Pro |
| Beneish M-Score Pro | Go Pro |
You may also be interested in these OREX related companies
OREX News
I've sold $VRTX right after the big jump and I won't buy above $40. I'll wait for $36 again, while I'm holding $AMRN, $DNDN & $OREX :-)
about 12 hours ago by mitrado
about 12 hours ago by mitrado
$ARNA rebounds after share offering last week at $5.50 $OREX $VVUS http://stks.co/3vPY
about 10 days ago by EPS_MomentuM
about 10 days ago by EPS_MomentuM
RT @Bleedblue: RT @newkidontheblock FDA follows Adcom rec 80 percent. $orex anyone? Was the 20% it DOES happen.
about 16 days ago by DutchFanBoy
about 16 days ago by DutchFanBoy
$ARNA close above 7$ will be very bullish as market wants a turn around Tuesday $VVUS $OREX $$
about 16 days ago by peterumble
about 16 days ago by peterumble
$ARNA looks stronger day by day means more upside to come yet, a good day will break 8$ this week $VVUS $OREX $$
about 16 days ago by peterumble
about 16 days ago by peterumble
@Bleedblue don't know about dates $orex i do TA mostly very little biotech $study but have a hunch from what i've read it is safer of the 2
about 17 days ago by Good2go
about 17 days ago by Good2go
@Bleedblue agree & the reason that $orex will follow $arna & 1 day possibly have the preferred drug (fda willing that is).
about 17 days ago by Good2go
about 17 days ago by Good2go
@DrNick This is strange, seeing $OREX only has two products in the pipeline... Kind of early move, eh!? ;-)
about 17 days ago by mitrado
about 17 days ago by mitrado
@DrNick $orex nice, thanks for the link. bought some today. not in $arna
about 17 days ago by Good2go
about 17 days ago by Good2go
Arena and Orexigen Compete to Bring First Weight Loss Drug to Market in Nearly 13 Years
May 14, 8:20AM Marketwire
May 14, 8:20AM Marketwire
Bank of America: Key Takeaways from Orexigen Therapeutics' Management Meetings
Apr 11, 10:27AM Benzinga
Apr 11, 10:27AM Benzinga
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| OREX | 3.35 | -0.07 | -2.05% | 231.67M |
| SWX | 41.98 | +0.24 | +0.57% | 1.924B |
| SWU | 117.64 | +0.51 | +0.44% | |
| SWS | 5.70 | -0.06 | -1.04% | 187.83M |
| SWN | 28.07 | -0.07 | -0.25% | 9.822B |
| SWM | 66.80 | +0.15 | +0.23% | 1.062B |
| SRLS | 4.01 | +0.00 | +0.00% | 80.64M |
| SRI | 7.06 | +0.11 | +1.58% | 195.50M |
| SREV | 11.99 | -0.05 | -0.42% | 891.92M |
| SRE | 65.10 | +0.55 | +0.85% | 15.54B |
